Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.

All technologies
 are listed as non-confidential technical summaries.

Technologies were generated by academic institutions, entrepreneurs, and corporations.

Click the Tech Search button below to have Whiteboard2Boardroom staff complete a personalized search for innovations to license from our research institution partners.

The most recent innovations from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available. 

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Use of Glycoproteins in Contraception and the Diagnosis of Human Infertility

To fertilize the human egg (oocyte), human sperm must first bind on the surface of the oocyte. The sperm binds to the oocytes via both the carbohydrate and protein portion of the glycoprotein. A human glycoprotein that is the equivalent to that on the oocyte can be used as a contraceptive agent by acting as a decoy. The carbohydrate sequences from these glycoproteins can also be used as agents, either singly or conjugated to polymers or other supports, for multiple uses including methods in the field of human infertility diagnosis. This discovery takes advantage of the unique species specific interactions between human sperm and oocytes.

-Large potential in the natural contraceptive market
-Species specific sperm binding assays

-Uses newly identified, species-specific oligosaccharides found on oocytes
-Only contraceptive agent that targets the mechanisms for the induction of the acrosome reaction 


Additional Details


University of Missouri - Columbia

Intellectual Property Protection

Pending Patent

Interested? Request More Information